Using Cryopreserved Plasmodium falciparum Sporozoites in a Humanized Mouse Model to Study Early Malaria Infection Processes and Test Prophylactic Treatments 31 August 2023
Development and application of a PBPK modeling strategy to support antimalarial drug development 15 August 2023 CPT Pharmacometrics Syst Pharmacol
Reaction hijacking inhibition of Plasmodium falciparum asparagine tRNA synthetase 26 July 2023 Res Sq
Moving seasonal malaria chemoprevention out of its geographical isolation 3 July 2023 Lancet Infect Dis
Annual Report 2022 26 June 2023 Read an in-depth overview of MMV's activities and our financial statements for 2022.
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial 12 June 2023 Lancet Infect Dis
Rectal artesunate for severe malaria, implementation research, Zambia 31 May 2023 Bull World Health Organ
Generation of a mutator parasite to drive resistome discovery in Plasmodium falciparum 26 May 2023 Nat Commun
Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study 22 May 2023 Lancet Infect Dis
Integration and application of new approach methodologies in assessing the developmental hazards: Case study with an antimalarial drug 22 May 2023 Birth Defects Res
Advances in Malaria Pharmacology and the online Guide to MALARIA PHARMACOLOGY: IUPHAR Review X 20 May 2023
Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline 9 May 2023 American Society for Microbiology
Predicting Optimal Antimalarial Drug Combinations from a Standardized Plasmodium falciparum Humanized Mouse Model 3 May 2023 Antimicrobial Agents and Chemotherapy
Comparative Susceptibility of Plasmodium ovale and Plasmodium falciparum Field Isolates to Reference and Lead Candidate Antimalarial Drugs in Ghana 24 April 2023 American Society for Microbiology
The impact of community delivery of intermittent preventive treatment of malaria in pregnancy on its coverage in four sub-Saharan African countries (Democratic Republic of the Congo, Madagascar, Mozambique, and Nigeria) 11 April 2023
Facilitators and barriers to seasonal malaria chemoprevention (SMC) uptake in Nigeria: a qualitative approach 10 April 2023 Malar J
Keeping the Promise: Product Development Partnerships’ Role in the New Age of Health Research and Product Development 6 April 2023 PDPs remain the chief developers of innovative medical technologies for people suffering with diseases and health threats underserved by traditional markets.
Feasibility and Acceptability of a Strategy Deploying Multiple First-Line Artemisinin-Based Combination Therapies for Uncomplicated Malaria in the Health District of Kaya, Burkina Faso 27 March 2023 Trop Med Infect Dis
The five continuum of care criteria that should accompany rectal artesunate interventions: lessons learned from an implementation study in Malawi 25 March 2023
Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome 22 March 2023 Cell Chem Biol
Potent acyl-CoA synthetase 10 inhibitors kill Plasmodium falciparum by disrupting triglyceride formation 16 March 2023 Nat Commun
Study protocol for development of an options assessment toolkit (OAT) for national malaria programs in Asia Pacific to determine best combinations of vivax radical cure for their given contexts 9 March 2023 PLOS ONE
